The International Center for Genetic Disease and the Department of Health in Abu Dhabi are working together to advance precision medicine in the United Arab Emirates (UAE). Their collaboration focuses on clinical and translational research, skill development, technology sharing, and translating research into practical products. The goal is to personalize disease prevention, diagnosis, and treatment using cutting-edge precision medicine methods. Recently, the International Center for Genetic Disease, associated with Brigham and Women’s Hospital and Harvard Medical School, initiated a six-month program to educate 100 doctors in the UAE about clinical genomic medicine and genetic counseling. This collaborative effort with the Department of Health in Abu Dhabi and Khalifa University of Science and Technology aims to enhance global genomic capabilities and improve healthcare outcomes. Genomic medicine, guided by experts from Mass General Brigham and Harvard-affiliated institutions, tailors healthcare based on an individual’s genetic makeup. The program empowers UAE doctors to address genetic issues, aligning with the Emirati Genome Program’s objectives. The ultimate goal is to enhance patient care and public health in the UAE, as demonstrated by a recent event in Abu Dhabi that underscored a strong commitment to healthcare innovation.